Cover Image
市場調查報告書

婦產科醫療診斷的全球市場預測 2021年:產前檢查,唐氏症,HPV,妊娠檢驗,妊娠檢驗,泌尿道感染,乳癌檢驗、其他

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021

出版商 MarketsandMarkets 商品編碼 403796
出版日期 內容資訊 英文 279 Pages
訂單完成後即時交付
價格
Back to Top
婦產科醫療診斷的全球市場預測 2021年:產前檢查,唐氏症,HPV,妊娠檢驗,妊娠檢驗,泌尿道感染,乳癌檢驗、其他 Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021
出版日期: 2016年11月25日 內容資訊: 英文 279 Pages
簡介

全球婦產科醫療診斷市場規模,預計在預測期間內以7.9%的年複合成長率擴大,至2021年達到366億4,000萬美元。該市場的成長,起因於女性的感染疾病罹患率高,慢性疾病、文明病的發病率的上升,女性的妊娠檢驗相關的認識的高漲,及政府、保健機關的舉措等要素。

本報告提供全球婦產科醫療診斷市場相關調查,應用為基礎的次級市場詳細考察,主要企業其成長策略、近幾年的發展趨勢相關資訊,各終端用戶的考察與市場規模,各國市場規模與預測,及市場動態的考察等。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 婦產科醫療診斷:市場概要
  • 亞太地區:妊娠、妊娠檢驗市場,各產品類型
  • 婦產科醫療診斷市場地區概要
  • 地區混合:婦產科醫療診斷市場
  • 婦產科醫療診斷市場:已發展的市場 vs. 新興市場

第5章 婦產科醫療診斷的全球市場:概要

  • 簡介
  • 市場動態
    • 促進要素
    • 阻礙要素
    • 機會
    • 課題

第6章 婦產科醫療診斷的全球市場:產業考察

  • 簡介
  • 產業趨勢
  • 乳癌診斷臨床實驗評估

第7章 婦產科醫療診斷的全球市場:各應用領域

  • 簡介
  • 骨質疏鬆症檢驗
  • 乳癌檢驗
  • 卵巢癌檢驗
  • 子宮頸癌檢驗
  • 妊娠、妊娠檢驗
  • 產前遺傳檢測
  • 傳染病檢查
  • 性傳染病檢查
  • 超音波檢驗

第8章 婦產科醫療診斷的全球市場:各終端用戶

  • 簡介
  • 醫院、診所
  • 診斷、影像中心
  • 居家醫療

第9章 婦產科醫療診斷的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區 (APAC)
  • 其他 (RoW)

第10章 競爭情形

  • 概要
  • 策略基準
  • 競爭情形、趨勢

第11章 企業簡介

  • SIEMENS AG
  • QUEST DIAGNOSTICS INC.
  • HOLOGIC, INC.
  • F. HOFFMANN-LA ROCHE AG
  • PERKINELMER INC.
  • ALERE INC.
  • GE HEALTHCARE
  • BECTON, DICKINSON AND COMPANY
  • ABBOTT LABORATORIES
  • BIOMERIEUX SA
  • KONINKLIJKE PHILIPS N.V.

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 4774

The global women's health diagnostics market is projected to reach USD 36.64 billion by 2021, growing at a CAGR of around 7.9% during the forecast period. Growth in this market can be attributed to a number of factors such as high prevalence of infectious diseases in women, rising incidence of chronic and lifestyle-related disorders and increasing awareness about fertility testing in women and initiatives taken by government and health organizations. Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, high cost of diagnostic solutions and lack of trained laboratory technicians are some of the factors restraining the growth of this market.

The women health diagnostics market in this report is segmented by application and end users. Based on application, the market is segmented into osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease (STD) testing, and ultrasound. The osteoporosis segment is further divided into bone densitometry and in vitro blood tests. The ovarian cancer segment is divided into tumor marker tests, diagnostic imaging tests and others. The cervical cancer segment is sub segmented into PAP smear testing and HPV testing. The breast cancer testing segment is further divided into mammography systems, tumor marker tests, blood chemistries & blood cell count tests, biopsies, and other diagnostic imaging tests. Pregnancy and fertility testing market is sub segmented into lab-based testing, pregnancy self-test and ovulation prediction kits, ovulation prediction kits, fertility monitors and thermometers. The prenatal genetic screening & carrier testing segment is further divided into cystic fibrosis, Down syndrome and Edward syndrome, TORCH infections and others (fragile x-syndrome & tay-sachs diseases). Further on, the infectious disease testing market segment is sub segmented into methicillin-resistant staphylococcus aurea (MRSA), urinary tract infections (vaginal pH & vaginitis), hepatitis, tuberculosis and streptococcus testing. The sexually transmitted disease testing segment comprises Chlamydia Trachomatis and Neisseria Gonorrohoeae testing, HIV testing and other STD testing. The ultrasound segment covers breast imaging and ob/gyn imaging. In 2015, the breast cancer testing product segment accounted for the largest share of the women health diagnostics market. This market is primarily driven by the increasing incidence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques. Based on end user, the women health diagnostics market is segmented into three segments, namely, hospitals & clinics, home care, and diagnostic & imaging centers.

In 2015, North America accounted for the largest share to the global women health diagnostics market, followed by Europe, Asia-Pacific, and the RoW. Growth in the North American market is largely driven by the increasing prevalence of cancer among women in this region, the presence of a large number of players and their increasing efforts to expand presence in North America. Furthermore, the increasing prevalence of cancer among women and increasing demand for fertility testing kits and monitors in North American countries is augmenting the demand for diagnostic tests.

Some of the major players in the women health diagnostics market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMerieux SA (France), and Koninklijke Philips N.V. (Netherlands).

Research Coverage:

  • Detailed insights on all the submarkets, based on application (osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound), this can help market players to identify high growth segments in the women's health diagnostics market.
  • The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner.
  • Key insights and market sizing for the different end users of the women health diagnostics market namely, hospitals & clinics, home healthcare, and diagnostic & imaging centers.
  • Country-wise market size and forecast for all the sub segments. Thus, not only the high growth application and end user areas; the market size numbers provided in the report will also enable market players to identify key geographic markets, and thereby strategize global marketing efforts in order to achieve sustainable revenue growth in the coming years.
  • It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.

Reasons to Buy the Report:

The report will augment established firms as well as new entrants/smaller firms to measure the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by top players in the women health diagnostics market. The report analyzes the women's health diagnostics market by application, and end user across all regions
  • Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the women health diagnostics market
  • Market Development: Comprehensive information on the lucrative emerging markets by application, end user, and region
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the women health diagnostics market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and distribution networks, of leading players in the women health diagnostics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. WOMEN'S HEALTH DIAGNOSTICS: MARKET OVERVIEW
  • 4.2. APAC: PREGNANCY AND FERTILITY TESTING MARKET, BY PRODUCT TYPE (2015)
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE WOMEN'S HEALTH DIAGNOSTICS MARKET
  • 4.4. GEOGRAPGIC MIX: WOMEN'S HEALTH DIAGNOSTICS MARKET
  • 4.5. WOMEN'S HEALTH DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. KEY MARKET DYNAMICS
    • 5.2.1. KEY MARKET DRIVERS
      • 5.2.1.1. High prevalence of infectious diseases in women
      • 5.2.1.2. Rising incidence of chronic and lifestyle-related disorders in women
      • 5.2.1.3. Increasing awareness about fertility testing in women and initiatives by government and health organizations
      • 5.2.1.4. Increased adoption of POC and rapid diagnostic tests
      • 5.2.1.5. Growth in the number of private diagnostic and imaging centers
      • 5.2.1.6. PPPs are expected to enhance infrastructure in diagnostic imaging centers
    • 5.2.2. KEY MARKET RESTRAINTS
      • 5.2.2.1. High cost of diagnostic imaging systems and procedures
      • 5.2.2.2. Shortage of skilled laboratory technicians
    • 5.2.3. KEY MARKET OPPORTUNITIES
      • 5.2.3.1. Improving healthcare infrastructure in emerging markets
      • 5.2.3.2. Growing number of regulatory approvals for immunoassay diagnostic techniques
    • 5.2.4. KEY MARKET CHALLENGES
      • 5.2.4.1. Stringent regulatory guidelines
      • 5.2.4.2. Increasing adoption of refurbished diagnostic imaging systems

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. INDUSTRY TRENDS
    • 6.2.1. GROWING FOCUS ON MICROFLUIDICS- AND NANOTECHNOLOGY-BASED POC DEVICES FOR DIAGNOSTICS
      • 6.2.1.1. Microfluidics-based LOC devices for laboratory testing
      • 6.2.1.2. Evolution of paper-based microfluidic POC diagnostic devices
    • 6.2.2. RISING FOCUS OF MARKET COMPANIES ON PREGNANCY AND FERTILITY ISSUES IN EMERGING REGIONS
  • 6.3. CLINICAL TRIALS ASSESSMENT FOR BREAST CANCER DIAGNOSTICS

7. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. OSTEOPOROSIS TESTING
    • 7.2.1. BONE DENSITOMETRY
    • 7.2.2. IN VITRO BLOOD TESTS
  • 7.3. BREAST CANCER TESTING
    • 7.3.1. MAMMOGRAPHY
    • 7.3.2. BREAST CANCER TUMOR MARKER TESTS
    • 7.3.3. BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS
    • 7.3.4. BIOPSIES
    • 7.3.5. OTHER DIAGNOSTIC IMAGING TESTS
  • 7.4. OVC TESTING
    • 7.4.1. OVC TUMOR MARKER TESTS
    • 7.4.2. DIAGNOSTIC IMAGING TESTS
    • 7.4.3. OTHER TESTS
  • 7.5. CERVICAL CANCER TESTING
    • 7.5.1. PAP SMEAR
    • 7.5.2. HPV TESTING
  • 7.6. PREGNANCY AND FERTILITY TESTING
    • 7.6.1. LAB-BASED TESTING
    • 7.6.2. PREGNANCY TESTING AND OVULATION PREDICTION KITS
    • 7.6.3. FERTILITY MONITORS
  • 7.7. PRENATAL GENETIC SCREENING AND CARRIER TESTING
    • 7.7.1. CF
    • 7.7.2. DOWN'S SYNDROME AND EDWARDS' SYNDROME
    • 7.7.3. TORCH INFECTIONS
    • 7.7.4. OTHER DISEASES
  • 7.8. INFECTIOUS DISEASE TESTING
    • 7.8.1. MRSA TESTING
    • 7.8.2. UTI TESTING (VAGINAL PH & VAGINITIS)
    • 7.8.3. HEPATITIS TESTING
    • 7.8.4. TUBERCULOSIS TESTING
    • 7.8.5. OTHER INFECTIOUS DISEASES
  • 7.9. STD TESTING
    • 7.9.1. CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING
    • 7.9.2. HIV TESTING
    • 7.9.3. OTHER STD
  • 7.10. ULTRASOUND TESTS
    • 7.10.1. BREAST IMAGING
    • 7.10.2. OB/GYN IMAGING

8. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS AND CLINICS
  • 8.3. DIAGNOSTIC AND IMAGING CENTERS
  • 8.4. HOME CARE

9. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. U.K.
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. ROE
  • 9.4. APAC
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. ROAPAC
  • 9.5. ROW
    • 9.5.1. LATIN AMERICA
    • 9.5.2. MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. STRATEGIC BENCHMARKING
  • 10.3. COMPETITIVE SITUATIONS AND TRENDS
    • 10.3.1. PRODUCT LAUNCHES
    • 10.3.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.3.3. ACQUISITIONS
    • 10.3.4. REGULATORY APPROVALS

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. SIEMENS AG
  • 11.2. QUEST DIAGNOSTICS INC.
  • 11.3. HOLOGIC, INC.
  • 11.4. F. HOFFMANN-LA ROCHE AG
  • 11.5. PERKINELMER INC.
  • 11.6. ALERE INC.
  • 11.7. GE HEALTHCARE
  • 11.8. BECTON, DICKINSON AND COMPANY
  • 11.9. ABBOTT LABORATORIES
  • 11.10. BIOMERIEUX SA
  • 11.11. KONINKLIJKE PHILIPS N.V.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS
  • 12.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.6. AVAILABLE CUSTOMIZATIONS
  • 12.7. RELATED REPORTS
  • 12.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: RISING INCIDENCE OF CHRONIC AND LIFESTYLE-RELATED DISORDERS IN WOMEN ARE EXPECTED TO DRIVE MARKET GROWTH
  • TABLE 2: HIGH COST OF DIAGNOSTIC IMAGING SYSTEMS AND PROCEDURES IS AFFECTING THE RATE OF ADOPTION IN EMERGING MARKETS
  • TABLE 3: IMPROVING HEALTHCARE INFRASTRUCTURE IN EMERGING MARKETS IS EXPECTED TO PLAY A MAJOR ROLE IN GROWTH OF THE WOMEN'S HEALTH DIAGNOSTICS MARKET
  • TABLE 4: STRINGENT REGULATORY GUIDELINES POSE A CHALLENGE FOR DIAGNOSTIC DEVICE MANUFACTURERS
  • TABLE 5: WOMEN'S HEALTH DIAGNOSTICS MARKET: PRODUCT PORTFOLIO ANALYSIS
  • TABLE 6: GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 7: GLOBAL OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 8: GLOBAL OSTEOPOROSIS TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL BONE DENSITOMETRY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: GLOBAL IN VITRO BLOOD TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: GLOBAL BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 12: GLOBAL BREAST CANCER TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL MAMMOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL BREAST CANCER TUMOR MARKER TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: GLOBAL BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL BIOPSIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL OTHER DIAGNOSTIC IMAGING TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL OVC TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL OVC TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: GLOBAL OVC TUMOR MARKER TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL DIAGNOSTIC IMAGING TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL OTHER OVC TESTS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 23: GLOBAL CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 24: GLOBAL CERVICAL CANCER TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL PAP SMEAR MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL HPV TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: GLOBAL PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 28: GLOBAL PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: GLOBAL LAB-BASED TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: GLOBAL PREGNANCY AND OVULATION PREDICTION KITS TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: GLOBAL FERTILITY MONITORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: GLOBAL PRENATAL GENETIC SCREENING AND CARRIER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 33: GLOBAL PRENATAL GENETIC SCREENING AND CARRIER TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL CF MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL DOWN'S SYNDROME AND EDWARDS' SYNDROME MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: GLOBAL TORCH INFECTIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: GLOBAL OTHER DISEASES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: GLOBAL MRSA TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: GLOBAL UTI TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: GLOBAL HEPATITIS TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL OTHER INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 46: GLOBAL STD TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: GLOBAL HIV TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: GLOBAL OTHER STD MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 50: GLOBAL ULTRASOUND TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: GLOBAL ULTRASOUND TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: GLOBAL BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: GLOBAL OB/GYN MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 54: GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 55: GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE FOR HOSPITALS AND CLINICS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 56: GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE FOR DIAGNOSTIC AND IMAGING CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE FOR HOME CARE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 59: NORTH AMERICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: NORTH AMERICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 61: NORTH AMERICA: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: NORTH AMERICA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: NORTH AMERICA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 64: NORTH AMERICA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: NORTH AMERICA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
  • TABLE 66: NORTH AMERICA: STD TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: NORTH AMERICA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
  • TABLE 68: NORTH AMERICA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 69: NORTH AMERICA: OVC TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 71: U.S.: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 72: U.S.: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: U.S.: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: U.S.: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 75: U.S.: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 76: U.S.: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
  • TABLE 77: U.S.: STD TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 78: U.S.: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
  • TABLE 79: U.S.: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 80: U.S.: OVC TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 81: U.S.: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 82: CANADA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 83: CANADA: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: CANADA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: CANADA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 86: CANADA : PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 87: CANADA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
  • TABLE 88: CANADA : STD TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 89: CANADA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
  • TABLE 90: CANADA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 91: CANADA: OVC TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: CANADA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 93: EUROPE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
  • TABLE 94: EUROPE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 95: EUROPE: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: EUROPE: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: EUROPE: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 98: EUROPE: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 99: EUROPE: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 100: EUROPE: STD MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 101: EUROPE: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE,2014-2021 (USD MILLION)
  • TABLE 102: EUROPE: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: EUROPE: OVC TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
  • TABLE 104: EUROPE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 105: GERMANY: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 106: GERMANY: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 107: GERMANY: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: GERMANY: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 109: GERMANY: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 110: GERMANY: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 111: GERMANY: STD MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 112: GERMANY: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE,2014-2021 (USD MILLION)
  • TABLE 113: GERMANY: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 114: GERMANY: OVC TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 115: GERMANY: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 116: U.K.: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 117: U.K: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 118: U.K: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 119: U.K: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 120: U.K: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 121: U.K: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 122: U.K: STD MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: U.K: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 124: U.K: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 125: U.K: OVC TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
  • TABLE 126: U.K: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 127: FRANCE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 128: FRANCE: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 129: FRANCE: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 130: FRANCE: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 131: FRANCE: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 132: FRANCE: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 133: FRANCE: STD MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 134: FRANCE: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE,2014-2021 (USD MILLION)
  • TABLE 135: FRANCE: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 136: FRANCE: OVC TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
  • TABLE 137: FRANCE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 138: ITALY: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 139: ITALY: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 140: ITALY: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 141: ITALY: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 142: ITALY: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 143: ITALY: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 144: ITALY: STD MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 145: ITALY: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 146: ITALY: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 147: ITALY: OVC TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
  • TABLE 148: ITALY: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 149: SPAIN: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 150: SPAIN: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 151: SPAIN: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 152: SPAIN: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 153: SPAIN: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 154: SPAIN: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
  • TABLE 155: SPAIN: STD TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 156: SPAIN: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
  • TABLE 157: SPAIN: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 158: SPAIN: OVC TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 159: SPAIN: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 160: ROE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 161: ROE: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 162: ROE: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 163: ROE: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 164: ROE: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 165: ROE: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
  • TABLE 166: ROE: STD TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 167: ROE: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
  • TABLE 168: ROE: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 169: ROE: OVC TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 170: ROE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 171: APAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
  • TABLE 172: APAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
  • TABLE 173: APAC: BREAST CANCER TESTING, BY TYPE, (USD MILLION)
  • TABLE 174: APAC: OSTEOPOROSIS TESTING, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 175: APAC: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 176: APAC: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 177: APAC: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 178: APAC: STD MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 179: APAC: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 180: APAC: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 181: APAC: OVC MARKET SIZE, BY TESTING, 2014-2021 (USD MILLION)
  • TABLE 182: APAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 183: CHINA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 184: CHINA: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 185: CHINA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 186: CHINA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 187: CHINA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 188: CHINA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
  • TABLE 189: CHINA: STD TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 190: CHINA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
  • TABLE 191: CHINA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 192: CHINA: OVC TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 193: CHINA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 194: JAPAN: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
  • TABLE 195: JAPAN: BREAST CANCER TESTING, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 196: JAPAN: OSTEOPOROSIS TESTING, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 197: JAPAN: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021, (USD MILLION)
  • TABLE 198: JAPAN: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 199: JAPAN: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 200: JAPAN: STD MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 201: JAPAN: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 202: JAPAN: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 203: JAPAN: OVC MARKET SIZE, BY TESTING, 2014-2021 (USD MILLION)
  • TABLE 204: JAPAN: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 205: INDIA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
  • TABLE 206: INDIA: BREAST CANCER TESTING, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 207: INDIA: OSTEOPOROSIS TESTING, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 208: INDIA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 209: INDIA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 210: INDIA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 211: INDIA: STD MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 212: INDIA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
  • TABLE 213: INDIA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 214: INDIA: OVC MARKET SIZE, BY TESTING, 2014-2021 (USD MILLION)
  • TABLE 215: INDIA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 216: ROAPAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
  • TABLE 217: ROAPAC: BREAST CANCER TESTING, BY TYPE, (USD MILLION)
  • TABLE 218: ROAPAC: OSTEOPOROSIS TESTING, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 219: ROAPAC: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 220: ROAPAC: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 221: ROAPAC: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 222: ROAPAC: STD MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 223: ROAPAC: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 224: ROAPAC: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 225: ROAPAC: OVC MARKET SIZE, BY TESTING, 2014-2021, (USD MILLION)
  • TABLE 226: ROAPAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER (USD MILLION)
  • TABLE 227: ROW: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 228: ROW: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 229: ROW: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 230: ROW: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 231: ROW: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 232: ROW: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 233: ROW: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
  • TABLE 234: ROW: STD TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 235: ROW: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
  • TABLE 236: ROW: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 237: ROW: OVC TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 238: ROW: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 239: LATIN AMERICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 240: LATIN AMERICA: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 241: LATIN AMERICA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 242: LATIN AMERICA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 243: LATIN AMERICA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 244: LATIN AMERICA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
  • TABLE 245: LATIN AMERICA: STD TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 246: LATIN AMERICA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
  • TABLE 247: LATIN AMERICA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 248: LATIN AMERICA: OVC TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 249: LATIN AMERICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 250: MIDDLE EAST & AFRICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 251: MIDDLE EAST & AFRICA: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 252: MIDDLE EAST & AFRICA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 253: MIDDLE EAST & AFRICA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 254: MIDDLE EAST & AFRICA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 255: MIDDLE EAST & AFRICA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 256: MIDDLE EAST & AFRICA: STD MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 257: MIDDLE EAST & AFRICA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
  • TABLE 258: MIDDLE EAST & AFRICA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 259: MIDDLE EAST & AFRICA: OVC MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 260: MIDDLE EAST & AFRICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 261: GROWTH STRATEGY MATRIX (2013-2016)
  • TABLE 262: PRODUCT LAUNCHES, 2013-2016
  • TABLE 263: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
  • TABLE 264: ACQUISITIONS, 2013-2016
  • TABLE 265: REGULATORY APPROVALS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATION, 2016 VS. 2021
  • FIGURE 7: WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2016 VS. 2021
  • FIGURE 8: GEOGRAPHIC SNAPSHOT: WOMEN'S HEALTH DIAGNOSTICS MARKET
  • FIGURE 9: HIGH PREVALENCE OF INFECTIOUS DISEASES AND RISING INCIDENCE OF CHRONIC AND LIFESTYLE-RELATED DISORDERS IN WOMEN ARE DRIVING GROWTH IN THE WOMEN'S HEALTH DIAGNOSTICS MARKET
  • FIGURE 10: PREGNANCY TESTING AND OVULATION PREDICTION KITS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC PREGNANCY AND FERTILITY TESTING MARKET IN 2015
  • FIGURE 11: THE U.S. COMMANDED THE LARGEST SHARE OF THE WOMEN'S HEALTH DIAGNOSTICS MARKET IN 2015
  • FIGURE 12: APAC IS EXPECTED TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 13: DEVELOPING MARKETS ARE EXPECTED TO REGISTER HIGHER CAGRS DURING THE FORECAST PERIOD
  • FIGURE 14: WOMEN'S HEALTH DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: CLINICAL STUDIES FOR BREAST CANCER DIAGNOSTIC DEVICES (2013-2016)
  • FIGURE 16: BREAST CANCER SEGMENT IS EXPECTED TO DOMINATE THE MARKET IN 2016
  • FIGURE 17: MAMMOGRAPHY SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: UTIS TESTING SEGMENT IS EXPECTED TO DOMINATE THE MARKET IN 2016
  • FIGURE 19: THE HOSPITALS & CLINICS END-USER SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET UNTIL 2021
  • FIGURE 20: NORTH AMERICA:WOMEN'S HEALTH DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 21: EUROPE:WOMEN'S HEALTH DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 22: APAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 23: PRODUCT LAUNCH WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET COMPANIES FROM 2013 TO SEPTEMBER 2016
  • FIGURE 24: LIST OF NEW PRODUCT LAUNCHES BY KEY COMPANIES IN THE MARKET, 2014 - 2016
  • FIGURE 25: KEY ACQUISITIONS: WOMEN'S HEALTH DIAGNOSTICS MARKET, 2014-2016
  • FIGURE 26: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES ACCOUNTED FOR THE LARGEST SHARE FROM 2013 TO 2016
  • FIGURE 27: COMPANY SNAPSHOT: SIEMENS AG
  • FIGURE 28: COMPANY SNAPSHOT: QUEST DIAGNOSTICS INC.
  • FIGURE 29: COMPANY SNAPSHOT: HOLOGIC, INC.
  • FIGURE 30: COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE AG
  • FIGURE 31: COMPANY SNAPSHOT: PERKINELMER INC.
  • FIGURE 32: COMPANY SNAPSHOT: ALERE INC.
  • FIGURE 33: COMPANY SNAPSHOT: GE HEALTHCARE
  • FIGURE 34: COMPANY SNAPSHOT: BD
  • FIGURE 35: COMPANY SNAPSHOT: ABBOTT LABORATORIES
  • FIGURE 36: COMPANY SNAPSHOT: BIOMERIEUX SA
  • FIGURE 37: COMPANY SNAPSHOT: KONINKLIJKE PHILIPS N.V.
Back to Top